The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After Treatment

Overview of attention for article published in JAMA Oncology, July 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news: 8 news outlets
blogs: 1 blog

twitter: 33 X users
facebook: 2 Facebook pages

Readers on

mendeley: 53 Mendeley

Summary News Blogs X Facebook

So far, Altmetric has seen 37 X posts from 33 X users, with an upper bound of 492,221 followers.

Clinical Edge: Staging #BC Treated With Neoadjuvant #Chemotherapy. See the study by @JAMAOnc here: https://t.co/TSdyd0ZsRj

Reply Repost Favourite

RT @JAMAOnc: #BreastCancer outcome after neoadjuvant chemo predicted by Neo-Bioscore from ERBB2 & ER status, grade, stage https://t.co/AP22…

Reply Repost Favourite

RT @JAMAOnc: #BreastCancer outcome after neoadjuvant chemo predicted by Neo-Bioscore from ERBB2 & ER status, grade, stage https://t.co/AP22…

Reply Repost Favourite

RT @jamesian: New disease staging suggested by @MDAndersonNews 4 #breastcancer https://t.co/otyNkFQ6eW #bcsm #hcldr

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 33 additional X posts.